Cite

HARVARD Citation

    Shin, J. et al. (2022). Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1. Advanced science. 9 (5), p. n/a. [Online]. 
  
Back to record